Orphazyme A/S
HEAT SHOCK PROTEINS AND CHOLESTEROL HOMEOSTASIS
Last updated:
Abstract:
Provided herewith are bioactive agents that increase the intracellular concentration and/or activity of one or more heat shock proteins, including Hsp70, for use in the treatment of a disease associated with dysregulation of cholesterol homeostasis.
Status:
Application
Type:
Utility
Filling date:
30 Nov 2020
Issue date:
24 Jun 2021